Hanyu pharmaceutical's terlipressin acetate is approved by the Indonesian drug marketing license
-
Last Update: 2019-06-19
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On June 18, Hanyu pharmaceutical announced that the company had recently obtained the approval for listing of terlipressin acetate issued by the State Food and Drug Administration of Indonesia Terlipressin is a synthetic vasopressin analogue, which belongs to vasoconstrictor in vasoactive drugs It is mainly used for hemostasis of varicose hemorrhage in cirrhosis Now it is widely used in the treatment of hepatorenal syndrome, cirrhosis ascites, septic shock, burn, acute liver failure, cardiac arrest and so on The approval of this listing license indicates that terlipressin preparation of the company has obtained the access qualification of Indonesian market In the future, it will further expand the company's international market business, play a positive role in promoting the company's internationalization progress, contribute to the development of the company's export business and enhance the company's international competitiveness.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
